BSL3 Core Facility
The Biosafety Level 3 (BSL3) core facility is available for use by any researcher at the university whose work requires the manipulation of biological agents that may cause serious or potentially lethal disease as a result of exposure by the inhalation route. The BSL3 Core laboratory functions as a safe working environment for high-risk and high-security microbial pathogens. It is not a fee for service core, but functions instead as a core facility where properly trained users can manipulate various pathogenic microbes under safe conditions, protecting both the user, other university personnel, and the public from harm.
Users pay an hourly fee for use of the facility, which is charged out quarterly. The funds in the user account goes towards administrative fees, telecommunication charges, equipment service, and some user consumables such as certain components of personal protective equipment and safety and waste handling materials.
The Shared Resource Laboratories provide an extensive spectrum of trained personnel, innovative, leading edge services and instrumentation to all researchers at the University of Rochester School of Medicine and Dentistry.
Our highly skilled and continually trained technical personnel provide the proper and timely expertise to bridge the gaps between sophisticated instrumentation and biology. We favor an integrated approach to research yielding more insight and an answer to today’s increasingly complex questions.
The Shared Resource Laboratories (SRL) have invested $3 million in the last year in new state-of-the art instrumentation. These advanced technologies will enhance the University’s research capabilities in microscopy, mass spectrometry, genomics, and flow cytometry.
The SRL, which is directed by Tim Bushnell, Ph.D., provide leading edge services and instrumentation to researchers across the University. The new acquisitions were made possible through a combination of internal investment, NIH grant supplements, and NIH SIG grants.
John M. Ashton, Co-Director of UR’s Genomics Research Center (GRC) presented the results comparing single-cell RNA sequencing platforms at the annual meeting of the Association of Biomolecular Resource Facilities (ABRF) Conference in April 2018. The ABRF’s Genomics Research Group (GRG), that included members from across the nation, conducted the comparison.
Jackie Lillis, a Senior Bioinformatician in the Genomics Research Center (GRC) and Center of Pediatric Biomedical Research (CPBR), was selected to present a poster at the 59th Meeting of the American Society of Hematology to be held December 9 through 12, 2017 in Atlanta, Georgia. Her work, in collaboration with Jim Palis and his lab, is entitled ‘Single-Cell Transcriptome Analysis of Embryonic Erythro-Myeloid Progenitor Cells Reveals Lineage Heterogeneity’.
